Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Canadian energy explorer Talisman Energy Inc. ( TLM - Analyst Report ) offered a glimpse of its 2013 capital spending plans. The Calgary, Alberta-based oil and gas player said that it will reduce capital expenditures by about $1 billion in 2013, as it focuses on unlocking value through asset sale/joint venture partnerships and grow production from promising liquids rich areas in the Americas and Asia-Pacific.
Talisman – that sold a major portion of its North Sea operations last year to Chinese refining giant Sinopec ( SNP - Analyst Report ) for $1.5 billion – has pegged its 2013 capital budget at about $3 billion, down 25% from the $4 billion it invested last year. Of the total, roughly 90% will go toward liquids and international gas projects.
At the same time, Talisman disclosed that it is examining $2–$3 billion in non-core asset divestitures or joint ventures over the next year and half. The expected proceeds from the property sale – including those in the Montney and northern Duvernay formations in Western Canada – is likely to be used for debt reduction, finance short-term development plans and buy back shares.
Talisman, that has struggled to cope with low North American natural gas prices, also said that it expects its annual production to be in the range of 375–395 thousand oil-equivalent barrels per day (MBOE/d). The company guided towards liquids volume accounting for approximately 40% of the total output in 2013 (up from 35% in 2012), while international gas is supposed to make up a fourth of the total. Cash flow for the year is expected at around $2.5 billion.
Talisman currently carries a Zacks Rank #3 (Hold), implying that it is expected to perform in line with the broader U.S. equity market over the next one to three months.
Meanwhile, one can look at other Canadian upstream operators like ARC Resources Ltd. ( AETUF ) and Enerplus Corp. ( ERF - Snapshot Report ) as attractive investments. Both these firms – sporting a Zacks Rank #1 (Strong Buy) – offer value and are worth accumulating at current levels.
Read the full Analyst Report on SNP
Read the full Analyst Report on TLM
Read the full on AETUF
Read the full Snapshot Report on ERF